Current treatment of hypertension in patients with coronary artery disease recommended by different guidelines

Area of Science:

• Cardiology
• Hypertension Management
• Coronary Artery Disease Treatment

Background:

• Effective management of hypertension is crucial for patients with coronary artery disease (CAD).
• Current treatment strategies require updates based on evolving clinical guidelines.
• The 2015 American Heart Association/American College of Cardiology/American Society of Hypertension guidelines provide updated recommendations.

Purpose of the Study:

• To review and update treatment protocols for hypertension in patients diagnosed with CAD.
• To discuss the implications of the 2015 hypertension guidelines for CAD patient care.

Main Methods:

• A comprehensive literature search was conducted using Medline.
• Studies published between 1968 and 2015 were reviewed for treatment of hypertension in CAD patients.
• Data from 1977 to 2015 were specifically reported.

Main Results:

• Beta blockers combined with ACE inhibitors or ARBs are recommended for hypertension in CAD.
• Long-acting nitrates demonstrate efficacy in managing angina and ischemia.
• Calcium-channel blockers (CCBs) can be utilized as an adjunct therapy if angina persists.

Conclusions:

• The recommended treatment for hypertension in CAD patients includes beta blockers and ACE inhibitors or ARBs.
• Long-acting nitrates are effective for antianginal and anti-ischemic effects.
• CCBs are indicated for persistent angina despite optimal beta blocker and nitrate therapy.
• Blood pressure targets are <140/90 mmHg for patients ≤80 years and <150 mmHg systolic for patients ≥80 years.